CLYBL
Citramalyl-CoA lyase, mitochondrial
Also known as: CLB, CLYBL_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N0X4
- Gene
- CLYBL
- Ensembl
- ENSG00000125246
- Chromosome
- 13
- Canonical length
- 340 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins
- Quaternary structure
- Homotrimer
OverviewNCBI Gene
Enables (S)-citramalyl-CoA lyase activity; magnesium ion binding activity; and malate synthase activity. Involved in protein homotrimerization and regulation of cobalamin metabolic process. Located in mitochondrion. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
340 residues, UniProt reviewed canonical sequence.
>Q8N0X4|CLYBL
1 MALRLLRRAA RGAAAAALLR LKASLAADIP RLGYSSSSHH KYIPRRAVLY VPGNDEKKIK
61 KIPSLNVDCA VLDCEDGVAA NKKNEARLRI VKTLEDIDLG PTEKCVRVNS VSSGLAEEDL
121 ETLLQSRVLP SSLMLPKVES PEEIQWFADK FSFHLKGRKL EQPMNLIPFV ETAMGLLNFK
181 AVCEETLKVG PQVGLFLDAV VFGGEDFRAS IGATSSKETL DILYARQKIV VIAKAFGLQA
241 IDLVYIDFRD GAGLLRQSRE GAAMGFTGKQ VIHPNQIAVV QEQFSPSPEK IKWAEELIAA
301 FKEHQQLGKG AFTFQGSMID MPLLKQAQNT VTLATSIKEKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CLYBL can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 100 nTPM
Expression across tissuesHPA
Tissue
- liver: 100 nTPM
- choroid plexus: 65 nTPM
- tongue: 64 nTPM
- kidney: 59 nTPM
- skeletal muscle: 40 nTPM
- duodenum: 23 nTPM
Single-cell type
- choroid plexus epithelial cells: 518 nCPM
- renal collecting duct intercalated cells: 326 nCPM
- ependymal cells: 267 nCPM
- bergmann glia: 257 nCPM
- proximal tubule cells: 216 nCPM
- hepatocytes: 202 nCPM
Immune cell
- T-reg: 24 nTPM
- memory CD4 T-cell: 17 nTPM
- naive CD8 T-cell: 16 nTPM
- naive B-cell: 15 nTPM
- memory B-cell: 14 nTPM
- NK-cell: 14 nTPM
Brain region
- choroid plexus: 70 nTPM
- cerebellum: 46 nTPM
- cerebral cortex: 26 nTPM
- hippocampal formation: 26 nTPM
- basal ganglia: 24 nTPM
- amygdala: 23 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.31
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.08
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- protein homotrimerization
- positive regulation of cobalamin metabolic process
- regulation of cobalamin metabolic process
Molecular functions
- hydrolase activity
- magnesium ion binding
- (S)-citramalyl-CoA lyase activity
- malate synthase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Pyruvate/Phosphoenolpyruvate kinase-like domain superfamily
- Pyruvate kinase-like domain superfamily
- HpcH/HpaI aldolase/citrate lyase domain
- Citrate lyase beta subunit-like
- Citramalyl-CoA lyase
- HpcH/HpaI aldolase/citrate lyase
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CLYBL as an antibody target. Whether an autoantibody or antibody against CLYBL could matter depends on whether native CLYBL is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CLYBL is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CLYBL as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...